Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness

Critical Care Medicine

Volumn 37, Issue 9, 2009, Pages 2596-2603

  Woodske, Matthew E ^a   Yokoe, Takuya ^a   Zou, Baobo ^a   Romano, Lia C ^a   Rosa, Taylor C ^a   Garcia Ocana, Adolfo ^a   Alonso, Laura C ^a   O'Donnell, Christopher P ^a   McVerry, Bryan J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Critical illness; Glucose control; Hyperglycemia; Metabolism; Mortality; Sepsis

Indexed keywords

GLUCOSE; INSULIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BREATHING; CONTROLLED STUDY; CONVALESCENCE; CRITICAL ILLNESS; ENDOTOXEMIA; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN RELEASE; MALE; MORTALITY; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL;

EID: 69349089561     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181a9338a     Document Type: Article

References (36)

1. Pittas AG, Siegel RD, Lau J: Insulin therapy for critically ill hospitalized patients: A meta-analysis of randomized controlled trials. Arch Intern Med 2004; 164:2005-2011 (Pubitemid 39390557)
2. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367 (Pubitemid 34940724)
3. van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461 (Pubitemid 43200296)
4. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
5. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-2047 (Pubitemid 37430587)
6. Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300: 933-944
7. Mesotten D, Swinnen JV, Vanderhoydonc F, et al: Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004; 89:219-226 (Pubitemid 38183885)
8. van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195 (Pubitemid 40385286)
9. Turina M, Christ-Crain M, Polk HC: Diabetes and hyperglycemia: strict glycemic control. Crit Care Med 2006; 34(9 Suppl):S291-S300 (Pubitemid 44253716)
10. Marik PE, Raghavan M: Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med 2004; 30:748-756
11. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11:304-311 (Pubitemid 41248301)
12. Langouche L, Vanhorebeek I, Vlasselaers D, et al : Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115:2277-2286 (Pubitemid 41134169)
13. Leffler M, Hrach T, Stuerzl M, et al : Insulin attenuates apoptosis and exerts anti-inflammatory effects in endotoxemic human macrophages. J Surg Res 2007; 143:398-406 (Pubitemid 350101570)
14. Weekers F, Giulietti AP, Michalaki M, et al: Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003; 144:5329-5338 (Pubitemid 37476061)
15. Black HE, Rosenblum IY, Capen CC: Chemically induced (streptozotocin- alloxan) diabetes mellitus in the dog. Biochemical and ultrastructural studies. Am J Pathol 1980; 98: 295-310
16. Brenna O, Qvigstad G, Brenna E, et al: Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut. Dig Dis Sci 2003; 48:906-910 (Pubitemid 36470209)
17. Woodske ME, Yokoe T, Alonso LC, et al: Role of insulin and glucose modulation in an LPS-induced mouse model of sepsis. Amer J Resp Crit Care Med 2007; 175:A442
18. Woodske ME, Yokoe T, Zou B, et al: Insufficient insulin production predicts mortality in hyperglycemic septic mice. Am J Respir Crit Care Med 2008; 177:A117
19. Campen MJ, Tagaito Y, Jenkins TP, et al: Phenotypic differences in the hemodynamic response during REM sleep in six strains of inbred mice. Physiol Genomics 2002; 11: 227-234 (Pubitemid 37128739)
20. Alemzadeh R, Langley G, Upchurch L, et al: Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 1998; 83:1911-1915 (Pubitemid 28496315)
21. Quesada I, Nadal A, Soria B: Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Diabetes 1999; 48:2390-2397 (Pubitemid 30395431)
22. Song SH, Rhodes CJ, Veldhuis JD, et al : Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. Endocrinology 2003; 144:3399-3405
23. Fleiss JL, Tytun A, Ury HK: A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980; 36:343-346
24. Alonso LC, Yokoe T, Zhang P, et al: Glucose infusion in mice: a new model of beta cell replication. Diabetes 2007; 56:1792-1801 (Pubitemid 47025447)
25. Yokoe T, Alonso LC, Romano LC, et al: Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 2008; 586: 899-911. Epub 2007 Nov 22 (Pubitemid 351194126)
26. Altszuler N, Moraru E, Hampshire J: On the mechanism of diazoxide-induced hyperglycemia. Diabetes 1977; 26:931-935
27. Krogh-Madsen R, Moller K, Dela F, et al: Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab 2004; 286: E766-E772 (Pubitemid 38506948)
28. Archer LT, Benjamin B, Lane MM, et al: Renal gluconeogenesis and increased glucose utilization in shock. Am J Physiol 1976; 231: 872-879
29. Berk JL, Hagen JF, Beyer WH, et al: Hypoglycemia of shock. Ann Surg 1970; 171: 400-408
30. Filkins JP, Cornell RP: Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock. Am J Physiol 1974; 227: 778-781
31. Hinshaw LB, Beller BK, Archer LT, et al: Hypoglycemic response of blood to live Escherichia coli organisms and endotoxin. J Surg Res 1976; 21:141-150
32. Jeschke MG, Rensing H, Klein D, et al: Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005; 42:870-879 (Pubitemid 40693204)
33. Naylor JM, Kronfeld DS: In vivo studies of hypoglycemia and lactic acidosis in endotoxic shock. Am J Physiol 1985; 248: E309-E316
34. Wolfe RR, Elahi D, Spitzer JJ: Glucose and lactate kinetics after endotoxin administration in dogs. Am J Physiol 1977; 232: E180-E185 (Pubitemid 8077497)
35. Yelich MR, Witek-Janusek L: Glucose, lactate, insulin, and somatostatin responses to endotoxin in developing rats. Shock 1994; 2:438-444
36. Vila G, Maier C, Riedl M, et al: Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 2007; 92:3930-3934 (Pubitemid 47607643)